Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 3, 2011, Pages 492-500

  Cho, Hye Jin ^a   Seo, Yeon Seok ^a   Lee, Kwang Gyun ^a   Hyun, Jong Jin ^a   An, Hyonggin ^a   Keum, Bora ^a   Kim, Ji Hoon ^a   Yim, Hyung Joon ^a   Jeen, Yoon Tae ^a   Lee, Hong Sik ^a   Chun, Hoon Jai ^a   Um, Soon Ho ^a   Kim, Chang Duck ^a   Ryu, Ho Sang ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Alanine aminotransferase; FibroScan; Liver stiffness; Necroinflammation

Indexed keywords

AMINOTRANSFERASE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TRANSIENT ELASTOGRAPHY; VIRUS HEPATITIS;

EID: 79951616244     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06419.x     Document Type: Article

References (45)

1. Benvegnu L, Gios M, Boccato S etal. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744-9.
2. Lai CL, Ratziu V, Yuen MF etal. Viral hepatitis B. Lancet 2003; 362: 2089-94.
3. Poynard T, Yuen MF, Ratziu V etal. Viral hepatitis C. Lancet 2003; 362: 2095-100.
4. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36: S152-60.
5. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001; 344: 495-500.
6. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-81.
7. Colloredo G, Guido M, Sonzogni A etal. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 2003; 39: 239-44.
8. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
9. Siddique I, El-Naga HA, Madda JP etal. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand. J. Gastroenterol. 2003; 38: 427-32.
10. Maharaj B, Maharaj RJ, Leary WP etal. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-5.
11. Regev A, Berho M, Jeffers LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002; 97: 2614-8.
12. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
13. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003; 37: 972-4.
14. Colletta C, Smirne C, Fabris C etal. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-45.
15. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-13.
16. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
17. Gomez-Dominguez E, Mendoza J, Rubio S etal. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment. Pharmacol. Ther. 2006; 24: 513-8.
18. Friedrich-Rust M, Ong MF, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
19. Ganne-Carrie N, Ziol M, de Ledinghen V etal. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-7.
20. Wang JH, Changchien CS, Hung CH etal. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J. Gastroenterol. 2009; 44: 439-46.
21. Marcellin P, Ziol M, Bedossa P etal. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242-7.
22. Chan HL, Wong GL, Choi PC etal. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 2009; 16: 36-44.
23. Kim SU, Ahn SH, Park JY etal. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J. Clin. Gastroenterol. 2009; 43: 267-71.
24. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am. J. Surg. Pathol. 1995; 19: 1409-17.
25. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
26. Castera L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
27. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
28. Kettaneh A, Marcellin P, Douvin C etal. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007; 46: 628-34.
29. Arena U, Vizzutti F, Abraldes JG etal. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-93.
30. Lucidarme D, Foucher J, Le Bail B etal. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology. 2009; 49: 1083-9.
31. Coco B, Oliveri F, Maina AM etal. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 2007; 14: 360-9.
32. Lefkowitch JH, Schiff ER, Davis GL etal. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The hepatitis interventional therapy group. Gastroenterology. 1993; 104: 595-603.
33. Shimamatsu K, Kage M, Nakashima O etal. Pathomorphological study of HCV antibody-positive liver cirrhosis. J. Gastroenterol. Hepatol. 1994; 9: 624-30.
34. Sagir A, Erhardt A, Schmitt M etal. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-5.
35. Seo YS, Um SH, Suh SJ etal. Changes in liver stiffness during the course of acute hepatitis A. Korean J. Hepatol. 2008; 14: 465-73.
36. Fraquelli M, Rigamonti C, Casazza G etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
37. Arena U, Vizzutti F, Corti G etal. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-4.
38. Calvaruso V, Camma C, Di Marco V etal. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J. Viral Hepat. 2010; 17: 469-74.
39. Roulot D, Czernichow S, Le Clesiau H etal. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008; 48: 606-13.
40. Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 2006; 44: 513-4.
41. Sirli R, Sporea I, Tudora A etal. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J. Gastrointestin. Liver Dis. 2009; 18: 57-60.
42. Bissell DM. Sex and hepatic fibrosis. Hepatology 1999; 29: 988-9.
43. Yasuda M, Shimizu I, Shiba M etal. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999; 29: 719-27.
44. Colombo S, Belloli L, Buonocore M etal. Liver stiffness values in the normal population: a study in voluntary blood donors. Hepatology 2008; 48 (Suppl): A995.
45. Poynard T, Halfon P, Castera L etal. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin. Chem. 2007; 53: 1615-22.